Welcome to Medications.com

Eurand Q4 Loss Widens On Higher Costs - RTT News

Eurand intends to discuss the further development of EUR-1025, the company's proprietary once-a-day oral formulation of ondansetron hydrochloride, ...

Posted: Thu Mar 06 13:52:32 -0500 2008




Frequently Reported Side Effects of Ondansetron Hydrochloride

medication, acute pancreaitis, pancretitis, ondansetron
© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea